ROBERT BAFFI - 12 Jun 2025 Form 4 Insider Report for Neurogene Inc. (NGNE)

Role: Director
Signature: /s/ Donna M. Cochener as attorney-in-fact for Robert Baffi
Issuer symbol: NGNE
Transactions as of: 12 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 13 Jun 2025, 12:07:42 UTC
Previous filing: 17 Jun 2024
Next filing: 24 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
BAFFI ROBERT	Director	C/O NEUROGENE INC., 535 W 24TH STREET, 5TH FLOOR, NEW YORK	/s/ Donna M. Cochener as attorney-in-fact for Robert Baffi	13 Jun 2025	0001274826

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NGNE	Non-Qualified Stock Option (right to buy)	Award	$0	+12,050		$0.000000	12,050	12 Jun 2025	Common Stock	12,050	$20.40	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests as to 1/12 of the total shares monthly beginning July 12, 2025 until the option is fully vested on June 12, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.